| Section | Title | Authors | Address |
|---|
|
| Genes | ABCC10 (ATP-binding cassette, sub-family C (CFTR/MRP), member 10) | Hopper-Borge E, Domanitskaya N | http://atlasgeneticsoncology.org/Genes/ABCC10ID47655ch6p21.html |
| Genes | ACVRL1 (activin A receptor type II-like 1) | Ornati F, Vecchia L, Scotti C, Plumitallo S, Olivieri C | http://atlasgeneticsoncology.org/Genes/ACVRL1ID569ch12q13.html |
| Genes | ADAM23 (ADAM metallopeptidase domain 23) | Costa ET, Camargo AA | http://atlasgeneticsoncology.org/Genes/ADAM23ID44041ch2q33.html |
| Genes | ADAMTS15 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 15) | Cal S, Obaya AJ | http://atlasgeneticsoncology.org/Genes/ADAMTS15ID45587ch11q24.html |
| Genes | ADCYAP1 (adenylate cyclase activating polypeptide 1 (pituitary)) | Moody T | http://atlasgeneticsoncology.org/Genes/ADCYAP1ID43656ch18p11.html |
| Genes | ADRB2 (adrenoceptor beta 2, surface) | Oliveira DT, Bravo-Calderón DM | http://atlasgeneticsoncology.org/Genes/ADRB2ID43818ch5q32.html |
| Genes | AFAP1L2 (actin filament associated protein 1-like 2) | Bai X, Moodley S, Cho HR, Liu M | http://atlasgeneticsoncology.org/Genes/AFAP1L2ID52197ch10q25.html |
| Genes | AKAP12 A kinase (PRKA) anchor protein 12 | Gelman IH | http://atlasgeneticsoncology.org/Genes/AKAP12ID607ch6q25.html |
| Genes | AKT1S1 (AKT1 substrate 1 (proline-rich)) | Wiza C, Nascimento EBM, Ouwens DM | http://atlasgeneticsoncology.org/Genes/AKT1S1ID44289ch19q13.html |
| Genes | ATMIN (ATM Interactor) | Heierhorst J | http://atlasgeneticsoncology.org/Genes/ATMINID45745ch16q23.html |
| Genes | ATP2B4 (ATPase, Ca++ transporting, plasma membrane 4) | Bozgeyik E, Arman K, Igci YZ | http://atlasgeneticsoncology.org/Genes/ATP2B4ID51257ch1q32.html |
| Genes | ATP5B (ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide) | Bozgeyik E, Arman K, Igci YZ | http://atlasgeneticsoncology.org/Genes/ATP5BID51209ch12q13.html |
| Genes | AURKB (aurora kinase B) | Yeung SCJ | http://atlasgeneticsoncology.org/Genes/AURKBID731ch17p13.html |
| Genes | BAG3 (Bcl-2 associated athanogene 3) | d'Avenia M, Guerriero L, Rosati A, Turco MC | http://atlasgeneticsoncology.org/Genes/BAG3ID43160ch10q26.html |
| Genes | BIN1 (Bridging Integrator 1) | Thomas S, Chang MY, Prendergast GC | http://atlasgeneticsoncology.org/Genes/BIN1ID794ch2q14.html |
| Genes | BIRC6 (Baculoviral IAP repeat-containing 6) | Iris Luk SU, Wang Y | http://atlasgeneticsoncology.org/Genes/BIRC6ID798ch2p22.html |
| Genes | CADM4 (cell adhesion molecule 4) | Ito T, Murakami Y | http://atlasgeneticsoncology.org/Genes/CADM4ID46066ch19q13.html |
| Genes | CARD10 (caspase recruitment domain family, member 10) | Ayaz G, Muyan M | http://atlasgeneticsoncology.org/Genes/CARD10ID43187ch22q13.html |
| Genes | CASP7 (caspase 7, apoptosis-related cysteine peptidase) | Coutinho-Camillo CM, Soares FA | http://atlasgeneticsoncology.org/Genes/CASP7ID924ch10q25.html |
| Genes | CD74 (CD74 molecule, major histocompatibility complex, class II invariant chain) | Gil-Yarom N, Becker Herman S, Shachar I | http://atlasgeneticsoncology.org/Genes/CD74ID45843ch5q33.html |
| Genes | CDH3 (Cadherin 3, Type 1, P-Cadherin (Placental)) | Vieira AF, Ribeiro AS, Paredes J | http://atlasgeneticsoncology.org/Genes/CDH3ID40025ch16q22.html |
| Genes | CEBPA (CCAAT/enhancer binding protein (C/EBP), alpha) | Tian TV, Graf T | http://atlasgeneticsoncology.org/Genes/CEBPAID40050ch19q13.html |
| Genes | CELF2 (CUGBP, Elav-like family member 2) | Ramalingam S, Anant S | http://atlasgeneticsoncology.org/Genes/CELF2ID52815ch10p14.html |
| Genes | CHD6 (chromodomain helicase DNA binding protein 6) | Lathrop M, Rhodes CH, Fiering S | http://atlasgeneticsoncology.org/Genes/CHD6ID43211ch20q12.html |
| Genes | CHFR (Checkpoint with fork-head associated and ring finger) | Erson-Bensan AE, Akman HB, Petty EM | http://atlasgeneticsoncology.org/Genes/CHFRID526.html |
| Genes | CHST11 (carbohydrate (chondroitin 4) sulfotransferase 11) | Klüppel M | http://atlasgeneticsoncology.org/Genes/CHST11ID50474ch12q23.html |
| Genes | CTDSPL (CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase-Like) | Sarkar S, Maiti GP, Panda CK | http://atlasgeneticsoncology.org/Genes/CTDSPLID40189ch3p22.html |
| Genes | CXCL17 (chemokine (C-X-C motif) ligand 17) | Matsui A, Murakami T | http://atlasgeneticsoncology.org/Genes/CXCL17ID47679ch19q13.html |
| Genes | CXXC5 (CXXC finger protein 5) | Yaşar P, Muyan M | http://atlasgeneticsoncology.org/Genes/CXXC5ID52549ch5q31.html |
| Genes | DLX2 (distal-less homeobox 2) | Gitton Y, Levi G | http://atlasgeneticsoncology.org/Genes/DLX2ID52177ch2q31.html |
| Genes | DLX5 (distal-less homeobox 5) | Gitton Y, Levi G | http://atlasgeneticsoncology.org/Genes/DLX5ID44295ch7q21.html |
| Genes | DLX6 (distal-less homeobox 6) | Gitton Y, Levi G | http://atlasgeneticsoncology.org/Genes/DLX6ID52195ch7q21.html |
| Genes | ECM1 (extracellular matrix protein 1) | Gomez-Contreras PC, Lal G | http://atlasgeneticsoncology.org/Genes/ECM1ID40398ch1q21.html |
| Genes | EDIL3 (EGF-Like Repeats And Discoidin I-Like Domains 3) | Kitano H, Hidai C | http://atlasgeneticsoncology.org/Genes/EDIL3ID46078ch5q14.html |
| Genes | EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) | Scaggiante B, Bosutti A | http://atlasgeneticsoncology.org/Genes/EEF1A1ID40407ch6q13.html |
| Genes | EGR1 (Early Growth Response 1) | Lee YH | http://atlasgeneticsoncology.org/Genes/EGR1ID496ch5q31.html |
| Genes | EIF4B (eukaryotic translation initiation factor 4B) | Sbarrato T, Horvilleur E, Pöyry T, Willis AE | http://atlasgeneticsoncology.org/Genes/EIF4BID53571ch12q13.html |
| Genes | EMP3 (epithelial membrane protein 3) | Mellai M, Schiffer D | http://atlasgeneticsoncology.org/Genes/EMP3ID44238ch19q13.html |
| Genes | ENOX2 (ecto-NOX disulfide-thiol exchanger 2) | Tang X, Morré DM, Morré DJ | http://atlasgeneticsoncology.org/Genes/ENOX2ID40134chXq26.html |
| Genes | EP300 (E1A binding protein p300) | Negri G, Gervasini C | http://atlasgeneticsoncology.org/Genes/P300ID97.html |
| Genes | ERGIC3 (ERGIC and golgi 3) | Wu M, Cao Y | http://atlasgeneticsoncology.org/Genes/ERGIC3ID42222ch20q11.html |
| Genes | ETV6 (ets variant 6) | De Braekeleer E, Douet-Guilbert N, De Braekeleer M | http://atlasgeneticsoncology.org/Genes/ETV6ID38.html |
| Genes | EYA2 (EYA transcriptional coactivator and phosphatase 2) | Zhang L, Blevins MA, Ford HL, Zhao R | http://atlasgeneticsoncology.org/Genes/EYA2ID46126ch20q13.html |
| Genes | EZH2 (enhancer of zeste homolog 2 (Drosophila)) | Avan A, Maftouh M, Fiuji H, Giovannetti E, Peters GJ | http://atlasgeneticsoncology.org/Genes/EZH2ID40517ch7q36.html |
| Genes | FABP5 (fatty acid binding protein 5 (psoriasis-associated)) | Balcom E, Liu RZ, Poon S, Godbout R | http://atlasgeneticsoncology.org/Genes/FABP5ID49862ch8q21.html |
| Genes | FABP7 (fatty acid binding protein 7, brain) | Godbout R, Poon HY, Liu RZ | http://atlasgeneticsoncology.org/Genes/FABP7ID46256ch6p22.html |
| Genes | FAS (Fas cell surface death receptor) | Sanséau D, Legembre P | http://atlasgeneticsoncology.org/Genes/FASID207ch10q23.html |
| Genes | FBLN2 (fibulin 2) | Cal S, Obaya AJ | http://atlasgeneticsoncology.org/Genes/FBLN2ID52662ch3p25.html |
| Genes | FBXO11 (F-box protein 11) | Duan S, Pagano M | http://atlasgeneticsoncology.org/Genes/FBXO11ID52605ch2p16.html |
| Genes | FIP1L1 (factor interacting with PAPOLA and CPSF1) | Zamecnikova A, Al Bahar S | http://atlasgeneticsoncology.org/Genes/FIP1L1ID40577ch4q12.html |
| Genes | FOXQ1 (forkhead box Q1) | Christensen J, Anderle P | http://atlasgeneticsoncology.org/Genes/FOXQ1ID45906ch6p25.html |
| Genes | GADD45A (growth arrest and DNA-damage-inducible, alpha) | User SD, Muyan M | http://atlasgeneticsoncology.org/Genes/GADD45AID339ch1p31.html |
| Genes | GPX3 (Glutathione peroxidase 3) | Yu YP, Luo J | http://atlasgeneticsoncology.org/Genes/GPX3ID46158ch5q33.html |
| Genes | GRPR (Gastrin-Releasing Peptide Receptor) | Moody TW | http://atlasgeneticsoncology.org/Genes/GRPRID40759chXp22.html |
| Genes | GSTA1 (glutathione S-transferase alpha 1) | Savic-Radojevic A, Radic T | http://atlasgeneticsoncology.org/Genes/GSTA1ID40764ch6p12.html |
| Genes | GSTM1 (Glutathione S-transferase M1) | Pljesa-Ercegovac M, Matic M | http://atlasgeneticsoncology.org/Genes/GSTM1ID40768ch1p13.html |
| Genes | GUCY2C (guanylate cyclase 2C (heat stable enterotoxin receptor)) | Blomain ES, Waldman SA | http://atlasgeneticsoncology.org/Genes/GUCY2CID43303ch12p13.html |
| Genes | HDAC2 (histone deacetylase 2) | Bae HJ, Nam SW | http://atlasgeneticsoncology.org/Genes/HDAC2ID40803ch6q22.html |
| Genes | HELLS (Helicase, Lymphoid-Specific) | Muegge K, Geiman T | http://atlasgeneticsoncology.org/Genes/HELLSID40811ch10q23.html |
| Genes | HOXC8 (homeobox C8) | Huang S, Li Y | http://atlasgeneticsoncology.org/Genes/HOXC8ID45912ch12q13.html |
| Genes | HSPB8 (heat shock 22kDa protein 8) | Bollino D, Aurelian L | http://atlasgeneticsoncology.org/Genes/HSPB8ID43743ch12q24.html |
| Genes | HSPD1 (Heat Shock 60kDa Protein 1) | Cappello F, Conway de Macario E, Macario AJL | http://atlasgeneticsoncology.org/Genes/HSPD1ID40888ch2q33.html |
| Genes | ID2 (Inhibitor Of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein) | van Zelm MC | http://atlasgeneticsoncology.org/Genes/ID2ID436ch2p25.html |
| Genes | IGFBP6 (insulin-like growth factor binding protein 6) | Bach LA | http://atlasgeneticsoncology.org/Genes/IGFBP6ID40933ch12q13.html |
| Genes | IL17A (interleukin 17A) | Inoue N, Akazawa T | http://atlasgeneticsoncology.org/Genes/IL17AID40945ch6p12.html |
| Genes | IL1RN (interleukin 1 receptor antagonist) | Gómez-Flores-Ramos L, Torres-Flores J, Gallegos-Arreola MP | http://atlasgeneticsoncology.org/Genes/IL1RNID40953ch2q13.html |
| Genes | ILK (integrin-linked kinase) | Serrano I, McDonald P, Dedhar S | http://atlasgeneticsoncology.org/Genes/ILKID460ch11p15.html |
| Genes | ING1 (inhibitor of growth family, member 1) | Mouche A, Yaacoub K, Guillaudeux T, Pedeux R | http://atlasgeneticsoncology.org/Genes/ING1ID40974ch13q34.html |
| Genes | ING3 (inhibitor of growth family, member 3) | Mouche A, Yaacoub K, Guillaudeux T, Pedeux R | http://atlasgeneticsoncology.org/Genes/ING3ID40977ch7q31.html |
| Genes | IRF4 (interferon regulatory factor 4) | Shukla V, Lu R | http://atlasgeneticsoncology.org/Genes/IRF4ID231ch6p25.html |
| Genes | ITGA1 (integrin, alpha 1) | Boudjadi S, Beaulieu JF | http://atlasgeneticsoncology.org/Genes/ITGA1ID40999ch5q11.html |
| Genes | KITLG (KIT ligand) | Beghini A, Lazzaroni F | http://atlasgeneticsoncology.org/Genes/MGFID142.html |
| Genes | KLRK1 (killer cell lectin-like receptor subfamily K, member 1) | Lanier LL | http://atlasgeneticsoncology.org/Genes/KLRK1ID41094ch12p13.html |
| Genes | LDOC1 (leucine zipper, down-regulated in cancer 1) | Hsiao JR, Chang JY | http://atlasgeneticsoncology.org/Genes/LDOC1ID41137chXq27.html |
| Genes | LRIG3 (Leucine-Rich Repeats And Immunoglobulin-Like Domains 3) | Guo D, Mao F, Lei T | http://atlasgeneticsoncology.org/Genes/LRIG3ID47529ch12q14.html |
| Genes | MAFB (v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B) | Vicente-Dueñas C, González-Herrero I, García-Ramírez I, Sánchez-García I | http://atlasgeneticsoncology.org/Genes/MAFBID41236ch20q11.html |
| Genes | MAGEA3 (melanoma antigen family A, 3) | Das B, Suklabaidya S, Jain S, Baisakh MR, Senapati S | http://atlasgeneticsoncology.org/Genes/MAGEA3ID41247chXq28.html |
| Genes | MCM3 (minichromosome maintenance complex component 3) | Arman K, Bozgeyik E, Igci YZ | http://atlasgeneticsoncology.org/Genes/MCM3ID41319ch6p12.html |
| Genes | MICA (MHC class I polypeptide-related sequence A) | Ahmed Z, Askar M | http://atlasgeneticsoncology.org/Genes/MICAID41364ch6p21.html |
| Genes | MIR135A1 (microRNA 135a-1) | Navarro A, Díaz-Beyá M, Monzó M | http://atlasgeneticsoncology.org/Genes/MIR135A1ID50328ch3p21.html |
| Genes | MIR143 (MicroRNA 143) | Kwong A, Shin VY, Ho JCW | http://atlasgeneticsoncology.org/Genes/MIR143ID50848ch5q32.html |
| Genes | MIR200C (microRNA 200c) | Mutlu M, SaatÖ, Raza U, Eyüpoglu E, Yurdusev E, Sahin Ö | http://atlasgeneticsoncology.org/Genes/MIR200CID51054ch12p13.html |
| Genes | MKI67 (marker of proliferation Ki-67) | Ntzeros K, Stanier P, Mazis D, Kritikos N, Rozis M, Anesidis E, Antoniou C, Stamatakos M | http://atlasgeneticsoncology.org/Genes/MKI67ID41369ch10q26.html |
| Genes | MOAP1 (Modulator Of Apoptosis 1) | Ayaz G, Muyan M | http://atlasgeneticsoncology.org/Genes/MOAP1ID46494ch14q32.html |
| Genes | MTA3 (metastasis associated 1 family, member 3 ) | Brüning A, Mylonas I | http://atlasgeneticsoncology.org/Genes/MTA3ID41445ch2p21.html |
| Genes | NFE2L2 (nuclear factor, erythroid 2-like 2) | Manolakou SD, Ziros PG, Sykiotis GP | http://atlasgeneticsoncology.org/Genes/NFE2L2ID44284ch2q31.html |
| Genes | NKX2-3 (NK2 homeobox 3) | Lin Z, Hegarty JP, Floros J, Franke A | http://atlasgeneticsoncology.org/Genes/NKX2-3ID51779ch10q24.html |
| Genes | NR5A1 (nuclear receptor subfamily 5, group A, member 1) | Ruggiero C, Doghman M, Lalli E | http://atlasgeneticsoncology.org/Genes/NR5A1ID45858ch9q33.html |
| Genes | NTSR1 (neurotensin receptor 1 (high affinity)) | Saada S, Marget P, Abacci A, Fauchais AL, Jauberteau MO, Petit D, Lalloue F | http://atlasgeneticsoncology.org/Genes/NTSR1ID44217ch20q13.html |
| Genes | NUAK1 (NUAK family, SNF1-like kinase, 1) | Inazuka F, Esumi H | http://atlasgeneticsoncology.org/Genes/NUAK1ID46275ch12q23.html |
| Genes | ORAI3 (ORAI calcium release-activated calcium modulator 3) | Hasna J, Benzerdjeb N, Faouzi M, Ay AS, Kischel P, Hague F, Sevestre H, Ahidouch A, Ouadid-Ahidouch H | http://atlasgeneticsoncology.org/Genes/ORAI3ID51589ch16p11.html |
| Genes | OSGIN1 (oxidative stress induced growth inhibitor 1) | Hu J, Wang Y | http://atlasgeneticsoncology.org/Genes/OSGIN1ID45760ch16q23.html |
| Genes | P2RY8 (purinergic receptor P2Y, G-protein coupled, 8) | Mackarel J, Betts D, Smith O | http://atlasgeneticsoncology.org/Genes/P2RY8ID49813chXp22.html |
| Genes | PAX2 (Paired box gene 2) | Eccles M | http://atlasgeneticsoncology.org/Genes/PAX2ID41642ch10q24.html |
| Genes | PCSK4 (proprotein convertase subtilisin/kexin type 4) | Khatib M, Demoures B | http://atlasgeneticsoncology.org/Genes/PCSK4ID50716ch19p13.html |
| Genes | PCSK5 (Proprotein Convertase Subtilisin/Kexin Type 5) | Khatib M, Demoures B | http://atlasgeneticsoncology.org/Genes/PCSK5ID52105ch9q21.html |
| Genes | PCSK6 (proprotein convertase subtilisin/kexin type 6) | Khatib M, Demoures B | http://atlasgeneticsoncology.org/Genes/PCSK6ID41630ch15q26.html |
| Genes | PDCD5 (programmed cell death 5) | Chen Y, Li G | http://atlasgeneticsoncology.org/Genes/PDCD5ID41676ch19q13.html |
| Genes | PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) | Zamecnikova A, Al Bahar S | http://atlasgeneticsoncology.org/Genes/PDGFRAID143ch4q12.html |
| Genes | PDSS2 (prenyl (decaprenyl) diphosphate synthase, subunit 2) | Chen P, Chen Q | http://atlasgeneticsoncology.org/Genes/PDSS2ID890ch6q21.html |
| Genes | PERP (PERP, TP53 apoptosis effector) | Kazan HH, iÖzen C, Muyan M | http://atlasgeneticsoncology.org/Genes/PERPID50465ch6q23.html |
| Genes | PF4 (platelet factor 4) | Van Raemdonck K, Proost P, Van Damme J, Struyf S | http://atlasgeneticsoncology.org/Genes/PF4ID41693ch4q13.html |
| Genes | PF4V1 (Platelet Factor 4 Variant 1) | Van Raemdonck K, Proost P, Van Damme J, Struyf S | http://atlasgeneticsoncology.org/Genes/PF4V1ID44606ch4q13.html |
| Genes | PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2) | Rodríguez-García A, Fontova P, Simon H, Manzano A, Bartrons R, Navarro-Sabaté À | http://atlasgeneticsoncology.org/Genes/PFKFB2ID52100ch1q32.html |
| Genes | PHLDA1 (pleckstrin homology-like domain, family A, member 1) | Nagai MA | http://atlasgeneticsoncology.org/Genes/PHLDA1ID41707ch12q15.html |
| Genes | PIWIL2 (piwi-like RNA-mediated gene silencing 2) | Gao JX, Liu N, Wu HL | http://atlasgeneticsoncology.org/Genes/PIWIL2ID41724ch8p21.html |
| Genes | PLCG1 (Phospholipase C, Gamma 1) | Manso R | http://atlasgeneticsoncology.org/Genes/PLCG1ID44163ch20q12.html |
| Genes | PML (promyelocytic leukemia) | Rabellino A, Scaglioni PP | http://atlasgeneticsoncology.org/Genes/PMLID41.html |
| Genes | POU1F1 (POU class 1 homeobox 1) | Franc JL, Becquet D, François-bellan AM | http://atlasgeneticsoncology.org/Genes/POU1F1ID46362ch3p11.html |
| Genes | POU3F2 (POU class 3 homeobox 2) | Yazawa T | http://atlasgeneticsoncology.org/Genes/POU3F2ID45747ch6q16.html |
| Genes | PRAME (Preferentially Expressed Antigen In Melanoma) | Fulton J, Heery DM | http://atlasgeneticsoncology.org/Genes/PRAMEID41828ch22q11.html |
| Genes | PTK6 (protein tyrosine kinase 6) | Mathur PS, Tyner AL | http://atlasgeneticsoncology.org/Genes/PTK6ID41900ch20q13.html |
| Genes | PTPRA (protein tyrosine phosphatase, receptor type, A) | Huang J, Lai X, Zheng X | http://atlasgeneticsoncology.org/Genes/PTPRAID41923ch20p13.html |
| Genes | PYCARD (PYD and CARD domain containing) | Dunn JH, Fujita M | http://atlasgeneticsoncology.org/Genes/PYCARDID712ch16p12.html |
| Genes | RAD52 (RAD52 homolog (S. cerevisiae)) | Lok BH, Powell SN | http://atlasgeneticsoncology.org/Genes/RAD52ID349ch12p13.html |
| Genes | RANBP2 (RAN binding protein 2) | Di Cesare E, Lavia P | http://atlasgeneticsoncology.org/Genes/RANBP2ID483.html |
| Genes | RHOA (ras homolog gene family, member A) | Manso R | http://atlasgeneticsoncology.org/Genes/RHOAID42107ch3p21.html |
| Genes | RNASET2 (ribonuclease T2) | Acquati F | http://atlasgeneticsoncology.org/Genes/RNASET2ID518ch6q27.html |
| Genes | ROS1 (ROS proto-oncogene 1 , receptor tyrosine kinase) | Klempner SJ, Ou SH | http://atlasgeneticsoncology.org/Genes/ROS1ID42144ch6q22.html |
| Genes | RREB1 (Ras Responsive Element Binding Protein 1) | Franklin RB, Costello LC | http://atlasgeneticsoncology.org/Genes/RREB1ID51424ch6p24.html |
| Genes | RRM2 (ribonucleotide reductase M2) | Afrasiabi A, Fiuji F, Mirhafez R, Avan A | http://atlasgeneticsoncology.org/Genes/RRM2ID42175ch2p25.html |
| Genes | SERPINB3 (Serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 3) | Turato C, Pontisso P | http://atlasgeneticsoncology.org/Genes/SERPINB3ID42265ch18q21.html |
| Genes | SGK1 (serum/glucocorticoid regulated kinase 1) | Menniti M, Iuliano R, D'Antona L, Talarico C, Amato R, Perrotti N | http://atlasgeneticsoncology.org/Genes/SGK1ID42281ch6q23.html |
| Genes | SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)) | Chen WY | http://atlasgeneticsoncology.org/Genes/SIRT1ID44006ch10q21.html |
| Genes | SLC19A3 (solute carrier family 19 (thiamine transporter), member 3) | Kwong A, Shin VY, Ho JCW | http://atlasgeneticsoncology.org/Genes/SLC19A3ID45635ch2q36.html |
| Genes | SLC1A5 (solute carrier family 1 (neutral amino acid transporter), member 5) | Indiveri C, Pochini L, Galluccio M, Scalise M | http://atlasgeneticsoncology.org/Genes/SLC1A5ID42313ch19q13.html |
| Genes | SNCG (synuclein, gamma (breast cancer-specific protein 1)) | Surguchov A | http://atlasgeneticsoncology.org/Genes/SNCGID42343ch10q23.html |
| Genes | SOCS6 (Suppressor Of Cytokine Signaling 6) | Kazi JU, Flores-Morales A, Rönnstrand L | http://atlasgeneticsoncology.org/Genes/SOCS6ID42351ch18q22.html |
| Genes | SPINK1 (Serine Peptidase Inhibitor, Kazal Type 1) | Koistinen H, Itkonen O, Stenman UH | http://atlasgeneticsoncology.org/Genes/SPINK1ID42375ch5q32.html |
| Genes | STMN1 (stathmin 1) | Machado-Neto JA, Traina F | http://atlasgeneticsoncology.org/Genes/STMN1ID42443ch1p36.html |
| Genes | TET2 (tet methylcytosine dioxygenase 2) | Viguié F | http://atlasgeneticsoncology.org/Genes/TET2ID40597ch4q24.html |
| Genes | TGFBR2 (Transforming Growth Factor, Beta Receptor II (70/80kDa)) | Sivadas VP, Kannan S | http://atlasgeneticsoncology.org/Genes/TGFBR2ID372ch3p24.html |
| Genes | TMSB10 (thymosin beta 10) | Qiu X, Gu Y | http://atlasgeneticsoncology.org/Genes/TMSB10ID42595ch2p11.html |
| Genes | TNFRSF17 (tumor necrosis factor receptor superfamily, member 17) | Gillespie A, Sanchez E, TangG, Chen H, Berenson J | http://atlasgeneticsoncology.org/Genes/TNFRSF17ID42616ch16p13.html |
| Genes | TRIM27 (tripartite motif containing 27) | Zoumpoulidou G, Mittnacht S | http://atlasgeneticsoncology.org/Genes/TRIM27ID42092ch6p22.html |
| Genes | TWIST2 (twist family BHLH transcription factor 2) | Gasparotto D, Lorenzetto E | http://atlasgeneticsoncology.org/Genes/TWIST2ID43639ch2q37.html |
| Genes | USB1 (U6 snRNA biogenesis 1) | Colombo EA | http://atlasgeneticsoncology.org/Genes/USB1ID44608ch16q21.html |
| Genes | WWTR1 (WW domain containing transcription regulator 1) | Zhao Y, Yang X | http://atlasgeneticsoncology.org/Genes/WWTR1ID44545ch3q25.html |
| Genes | YPEL3 (yippee-like 3 (Drosophila)) | Güpür G, Muyan M | http://atlasgeneticsoncology.org/Genes/YPEL3ID51528ch16p11.html |
| Genes | YPEL5 (yippee-like 5 (Drosophila)) | Güpür G, Muyan M | http://atlasgeneticsoncology.org/Genes/YPEL5ID44614ch2p23.html |
| Genes | ZFX (zinc finger protein, X-linked) | Emadi-Baygi M | http://atlasgeneticsoncology.org/Genes/ZFXID43623chXp22.html |
| Genes | ZMYND10 (zinc finger, MYND-type containing 10) | Zhang X, Lerman MI, He Z | http://atlasgeneticsoncology.org/Genes/ZMYND10ID45815ch3p21.html |
| Leukemias | Unbalanced whole-arm translocation der(1;13) in hematologic malignancies | Zamecnikova A, Al Bahar S | http://atlasgeneticsoncology.org/Anomalies/der0113q10q10ID1653.html |
| Leukemias | del(12)(q24q24) SETD1B/GTF2H3 | Storlazzi CT, Pieri L, Paoli C, Daniele G, Lasho T, Tefferi A, Vannucchi AM | http://atlasgeneticsoncology.org/Anomalies/del12q24q24ID1707.html |
| Leukemias | del(4)(q12q12) FIP1L1/PDGFRA | Zamecnikova A, Al Bahar S | http://atlasgeneticsoncology.org/Anomalies/del4q12q12ID1213.html |
| Leukemias | dic(9;16)(p13;q11) PAX5/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0916p13q11ID1686.html |
| Leukemias | dic(9;17)(p13;q11) PAX5/TAOK1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0917p13q11ID1598.html |
| Leukemias | inv(2)(p23q13) RANBP2/ALK | Seo EJ | http://atlasgeneticsoncology.org/Anomalies/inv2p23q13ID1710.html |
| Leukemias | inv(3)(q21q26) RPN1/MECOM | Smol T | http://atlasgeneticsoncology.org/Anomalies/inv3ID1006.html |
| Leukemias | t(10;11)(p12;q23) KMT2A/NEBL | Meyer C, Emerenciano M, Pombo-de-Oliveira MS, Marschalek R | http://atlasgeneticsoncology.org/Anomalies/t1011p12q23ID1702.html |
| Leukemias | t(10;11)(q22;q23) KMT2A/TET1 | Ittel A | http://atlasgeneticsoncology.org/Anomalies/t1011q22q23ID1410.html |
| Leukemias | t(10;17)(p15;q21) ZMYND11/MBTD1 | De Braekeleer E, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t1017p15q21ID1234.html |
| Leukemias | t(11;14)(p15;q22) AP2A2/NID2 | Douet-Guilbert N, De Braekeleer E, Tous C, Guéganic N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t1114p15q22ID1677.html |
| Leukemias | t(11;19)(q23;p13) KMT2A/SH3GL1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1119q23p13ID1194.html |
| Leukemias | t(11;21)(p14;q22) RUNX1/KIAA1549L | Abe A | http://atlasgeneticsoncology.org/Anomalies/t1121p14q22ID1703.html |
| Leukemias | t(11;22)(q13;q13) HRASLS5/PHF21B | Douet-Guilbert N, De Braekeleer E, Tous C, Guéganic N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t1122q13q13ID1676.html |
| Leukemias | t(12;13)(p13;q12) ETV6/FLT3 | De Braekeleer E, Douet-Guilbert N, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t1213p13q12ETV6FLT3ID1495.html |
| Leukemias | t(14;17)(q32;q21) IGH/IGF2BP1 | Gu G, South S | http://atlasgeneticsoncology.org/Anomalies/t1417q32q21IGH-IGF2BP1ID1706.html |
| Leukemias | t(1;2)(q12;q37) in acute leukemias | Shen Y, Gillan T, Bruyère H | http://atlasgeneticsoncology.org/Anomalies/t0102q12q37ID1317.html |
| Leukemias | t(1;9)(p13;p12) PAX5/HIPK1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0109p13p12ID1557.html |
| Leukemias | t(2;11)(q33;q23) KMT2A/ABI2 | Coenen EA, Zwaan CM, van den Heuvel-Eibrink MM, Meyer C, Marschalek R, Creutzig U, Pieters R, Bradtke J. | http://atlasgeneticsoncology.org/Anomalies/t0211q33q23ID2159.html |
| Leukemias | t(2;8)(q12;p11) RANBP2/FGFR1 | Gervais C | http://atlasgeneticsoncology.org/Anomalies/t0208q12p11ID1661.html |
| Leukemias | t(2;9)(p23;q33) TRAF1/ALK | Xing X, Feldman AL | http://atlasgeneticsoncology.org/Anomalies/t0209p23q33ID1685.html |
| Leukemias | t(3;12)(q26;p13) ETV6/MECOM | De Braekeleer E, Douet-Guilbert N, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t0312ID1008.html |
| Leukemias | t(4;17)(q12;q21) FIP1L1/RARA | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0417q12q21ID1470.html |
| Leukemias | t(5;11)(q35;q12) NSD1/FEN1 | Douet-Guilbert N, De Braekeleer E, Tous C, Guéganic N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t0511q35q12ID1679.html |
| Leukemias | t(5;12)(q33;p13) ATF7IP/PDGFRB | Kobayashi K | http://atlasgeneticsoncology.org/Anomalies/t0512q33p13ID1708.html |
| Leukemias | t(5;9)(q14.1;p24) SSBP2/JAK2 | Morgan EA, Dal Cin P | http://atlasgeneticsoncology.org/Anomalies/t0509q14p24ID1680.html |
| Leukemias | t(6;20)(q13;q12) LMBRD1/CHD6 | Douet-Guilbert N, De Braekeleer E, Tous C, Guéganic N, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t0620q13q12ID1678.html |
| Leukemias | t(7;17)(q11;q21) GTF2I/RARA in APL | Zhang GS | http://atlasgeneticsoncology.org/Anomalies/t0717q11q21ID1711.html |
| Leukemias | t(7;9)(q11;p12) PAX5/POM121 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0709q11p12ID1558.html |
| Leukemias | t(8;16)(p11;p13) KAT6A/CREBBP | Smol T, Collonge-Rame MA | http://atlasgeneticsoncology.org/Anomalies/t0816ID1018.html |
| Leukemias | t(9;12)(p24;p13) ETV6/JAK2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Leukemias | t(9;12)(q34;p13) ETV6/ABL1 | De Braekeleer E, Douet-Guilbert N, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t912ID1080.html |
| Leukemias | t(9;13)(p12;q21) PAX5/DACH1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0913p12q21ID1560.html |
| Leukemias | t(9;15)(p13;q24) PAX5/GOLGA6A | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0915p13q24ID1596.html |
| Leukemias | t(9;15)(p13;q24) PAX5/PML | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0915p13q24ID1561.html |
| Leukemias | t(9;17)(p13;p12) PAX5/NCOR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0917p13p12ID1597.html |
| Leukemias | t(9;22)(p13;q13) PAX5/BRD1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0922p13q13ID1562.html |
| Leukemias | t(9;9)(p13;p24) PAX5/JAK2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Bone: Epithelioid hemangioendothelioma with t(1;3)(p36;q25) WWRT1/CAMTA1 | Mavrogenis AF, Angelini A, Errani C, Ruggieri P | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Lung: Adenocarcinoma with t(6;12)(q22;q14.1) LRIG3/ROS1 | Sakamoto K, Togashi Y, Takeuchi K | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Lung: Mesothelioma with t(14;22)(q32;q12) EWSR1/YY1 | Panagopoulos I | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Lung: Translocations in Adenocarcinoma | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Lung: Translocations in Small Cell Carcinoma | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Lung: Translocations in Squamous Cell Carcinoma | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Soft Tissues: Lipoblastoma with t(2;8)(q32;q12.1) COL3A1/PLAG1 | Yoshida H, Miyachi M, Hosoi H | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Soft Tissues: Lipoblastoma with t(8;8)(q12;q12) RAB2A/PLAG1 | Yoshida H, Miyachi M, Hosoi H | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Soft Tissues: Lipoma with t(1;12)(p32;q14) HMGA2/PPAP2B | Bianchini L | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Soft Tissues: Pseudomyogenic hemangioendothelioma with t(7;19)(q22;q13) SERPINE1/FOSB | Walther C, Mertens F | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Thyroid: Papillary carcinoma with inv(10)(p12.1q11.2) ACBD5/RET | Hamatani K, Koyama K, Hayashi Y, Kusunoki Y | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Solid Tumors | Uterus: Low-grade endometrial stromal sarcoma with t(X;17)(p11.2;q21.33) MBTD1/CXorf6 | Dewaele B, Debiec-Rychter M | http://atlasgeneticsoncology.org/Anomalies/t0909p13p24ID1559.html |
| Cancer-Prones | Birt-Hogg-Dubé syndrome (BHDS) | Maffé A, Toschi B, Genuardi M | http://atlasgeneticsoncology.org/Kprones/BirtHoggDubeID10091.html |
| Deep Insights | CD47, a multi-facetted target for cancer immunotherapy | Wiersma VR, van Bommel PE, de Bruyn M, Helfrich W, Bremer E | http://atlasgeneticsoncology.org/Deep/CD47TumAndImmunoID20140.html |
| Deep Insights | Class III beta-tubulin, drug resistance and therapeutic approaches in cancers | Karki R, Ferlini C | http://atlasgeneticsoncology.org/Deep/ClassIIIbetatubulinID20135.html |
| Deep Insights | Deep Insight Into YPEL3 | Miller KLR, Yelton L | http://atlasgeneticsoncology.org/Deep/YPEL3DeepID20141.html |
| Deep Insights | FOXP3 expression in tumor cells and its role in cancer progression | Uva V, Sfondrini L, Triulzi T, Casalini P, Tagliabue E, Balsari A | http://atlasgeneticsoncology.org/Deep/FOXP3andCancerID20138.html |
| Deep Insights | Insights into structure and function of human PWWP domains | Qin S, Min J | http://atlasgeneticsoncology.org/Deep/PWWPDomainsID20137.html |
| Deep Insights | Mechanisms of rDNA silencing and the Nucleolar Remodelling Complex (NoRC) | McKeown PC | http://atlasgeneticsoncology.org/Deep/NoRCID20134.html |
| Deep Insights | Predicted human structural clusters of miRNAs target cancer genes | Mathelier A, Carbone A | http://atlasgeneticsoncology.org/Deep/miRNAsClustersID20136.html |
| Deep Insights | Th17 cells: inflammation and regulation | Masuda K, Kishimoto T | http://atlasgeneticsoncology.org/Deep/Th17CellsID20132.html |
| Deep Insights | The Hippo Kinase Pathway: a master regulator of proliferation, development and differentiation | Lo Sardo F, Strano S, Blandino G | http://atlasgeneticsoncology.org/Deep/HippoKinasePathwayID20125.html |
| Deep Insights | The nuclear pore complex: structure and function | Duheron V, Fahrenkrog B | http://atlasgeneticsoncology.org/Deep/NuclearPoreFunctionID20139.html |
| Deep Insights | The tumour suppressor function of the scaffolding protein spinophilin | Sarrouilhe D, Ladeveze V | http://atlasgeneticsoncology.org/Deep/SpinophilinID20133.html |
